241 related articles for article (PubMed ID: 23701009)
21. Chemometric modeling, docking and in silico design of triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors as antimalarials.
Ojha PK; Roy K
Eur J Med Chem; 2010 Oct; 45(10):4645-56. PubMed ID: 20708304
[TBL] [Abstract][Full Text] [Related]
22. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
23. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.
Sharma R; Patil S; Maurya P
SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770
[TBL] [Abstract][Full Text] [Related]
24. Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase.
Nguyen C; Ruda GF; Schipani A; Kasinathan G; Leal I; Musso-Buendia A; Kaiser M; Brun R; Ruiz-Pérez LM; Sahlberg BL; Johansson NG; Gonzalez-Pacanowska D; Gilbert IH
J Med Chem; 2006 Jul; 49(14):4183-95. PubMed ID: 16821778
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore modeling of substituted 1,2,4-Trioxanes for quantitative prediction of their antimalarial activity.
Gupta AK; Chakroborty S; Srivastava K; Puri SK; Saxena AK
J Chem Inf Model; 2010 Aug; 50(8):1510-20. PubMed ID: 20726605
[TBL] [Abstract][Full Text] [Related]
26. Design of antimalarial transmission blocking agents: Pharmacophore mapping of ligands active against stage-V mature gametocytes of
Aher RB; Roy K
J Biomol Struct Dyn; 2019 Sep; 37(14):3660-3673. PubMed ID: 30238847
[TBL] [Abstract][Full Text] [Related]
27. In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening.
Batool S; Khan ZA; Kamal W; Mushtaq G; Kamal MA
Med Chem; 2015; 11(7):687-700. PubMed ID: 25741881
[TBL] [Abstract][Full Text] [Related]
28. QSAR study on the antimalarial activity of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.
Hou X; Chen X; Zhang M; Yan A
SAR QSAR Environ Res; 2016; 27(2):101-24. PubMed ID: 26911561
[TBL] [Abstract][Full Text] [Related]
29. The current status of antimalarial drug research with special reference to application of QSAR models.
Ojha PK; Roy K
Comb Chem High Throughput Screen; 2015; 18(2):91-128. PubMed ID: 25543681
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: exploring the purine salvage pathway to design new antimalarial drugs.
Kagami LP; das Neves GM; Rodrigues RP; da Silva VB; Eifler-Lima VL; Kawano DF
Mol Divers; 2017 Aug; 21(3):677-695. PubMed ID: 28523625
[TBL] [Abstract][Full Text] [Related]
31. Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.
Hoelz LV; Calil FA; Nonato MC; Pinheiro LC; Boechat N
Future Med Chem; 2018 Aug; 10(15):1853-1874. PubMed ID: 30019917
[TBL] [Abstract][Full Text] [Related]
32. Modelling and informatics in the analysis of P. falciparum DHFR enzyme inhibitors.
Adane L; Bharatam PV
Curr Med Chem; 2008; 15(16):1552-69. PubMed ID: 18673224
[TBL] [Abstract][Full Text] [Related]
33. Exploring clotrimazole-based pharmacophore: 3D-QSAR studies and synthesis of novel antiplasmodial agents.
Brogi S; Brindisi M; Joshi BP; Sanna Coccone S; Parapini S; Basilico N; Novellino E; Campiani G; Gemma S; Butini S
Bioorg Med Chem Lett; 2015 Nov; 25(22):5412-8. PubMed ID: 26428874
[TBL] [Abstract][Full Text] [Related]
34. Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies.
Dahiya L; Mahapatra MK; Kaur R; Kumar V; Kumar M
Comb Chem High Throughput Screen; 2017; 20(4):310-320. PubMed ID: 28302016
[TBL] [Abstract][Full Text] [Related]
35.
Vaghefinezhad N; Farsani SF; Gharaghani S
Curr Drug Discov Technol; 2021; 18(1):139-157. PubMed ID: 31721705
[TBL] [Abstract][Full Text] [Related]
36. In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase.
Wadood A; Ulhaq ZU
J Mol Graph Model; 2013 Mar; 40():40-7. PubMed ID: 23353582
[TBL] [Abstract][Full Text] [Related]
37. Investigation of acyclic uridine amide and 5'-amido nucleoside analogues as potential inhibitors of the Plasmodium falciparum dUTPase.
Hampton SE; Schipani A; Bosch-Navarrete C; Recio E; Kaiser M; Kahnberg P; González-Pacanowska D; Johansson NG; Gilbert IH
Bioorg Med Chem; 2013 Sep; 21(18):5876-85. PubMed ID: 23916149
[TBL] [Abstract][Full Text] [Related]
38. Ligand based validated comparative chemometric modeling and pharmacophore mapping of aurone derivatives as antimalarial agents.
Adhikari N; Halder AK; Mondal C; Jha T
Curr Comput Aided Drug Des; 2013 Sep; 9(3):417-32. PubMed ID: 24010937
[TBL] [Abstract][Full Text] [Related]
39. Pharmacophoric studies of in vitro inhibition of Plasmodium falciparum growth.
Hariharan S
Indian J Biochem Biophys; 2012 Apr; 49(2):101-8. PubMed ID: 22650007
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationship study of antimalarial indolo [2,1-b]quinazoline-6,12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates.
Bhattacharjee AK; Hartell MG; Nichols DA; Hicks RP; Stanton B; van Hamont JE; Milhous WK
Eur J Med Chem; 2004 Jan; 39(1):59-67. PubMed ID: 14987834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
